Atara Biotherapeutics (ATRA) Earnings
|
Expand Research on ATRA
| Next EPS Date | N/A | EPS Growth Rate | +106.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -836.9% | Revenue Growth Rate | -38.6% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/25  |
Q225 | N/A | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/25 | Q225 | $0.19 | $0.00 | +$0.19 | $17.58M | N/A | N/A |  | | Details | |
| 5/15/25 | Q125 | $3.50 | $0.00 | +$3.50 | $98.15M | N/A | N/A | | | Details | |
| 8/12/24 | Q224 | -$3.10 | -$0.09 | -$3.01 | $28.64M | $37.09M | N/A | | | Details | |
| 5/8/24 | Q124 | N/A | -$0.23 | N/A | N/A | $27.92M | N/A | N/A | N/A | ||
| 3/25/24 | Q423 | N/A | -$0.45 | N/A | N/A | $2.83M | N/A | N/A | N/A | ||
| 3/19/24 | Q423 | N/A | -$0.45 | N/A | N/A | $2.83M | N/A | N/A | N/A | ||
| 3/11/24 | Q423 | N/A | -$0.45 | N/A | N/A | $2.83M | N/A | N/A | N/A |
